Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double‐blind, placebo‐controlled trial

AIM: No effective pharmacological interventions have been developed for patients with methamphetamine use disorder. Ifenprodil is a blocker of G protein‐activated inwardly rectifying potassium channels, which play a key role in the mechanism of action of addictive substances. We conducted a randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotajima‐Murakami, Hiroko, Takano, Ayumi, Hirakawa, Shinya, Ogai, Yasukazu, Funada, Daisuke, Tanibuchi, Yuko, Ban, Eriko, Kikuchi, Minako, Tachimori, Hisateru, Maruo, Kazushi, Kawashima, Takahiro, Tomo, Yui, Sasaki, Tsuyoshi, Oi, Hideki, Matsumoto, Toshihiko, Ikeda, Kazutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919120/
https://www.ncbi.nlm.nih.gov/pubmed/35068087
http://dx.doi.org/10.1002/npr2.12232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919120/
https://www.ncbi.nlm.nih.gov/pubmed/35068087
http://dx.doi.org/10.1002/npr2.12232

Ejemplares similares